149 related articles for article (PubMed ID: 37863815)
1. Evaluation of Multiple Liver Cancer Scoring Systems.
Sun J; Qi C; Liu Y; Gao F; Fu X; Tian Y
Adv Biol (Weinh); 2024 Feb; 8(2):e2300301. PubMed ID: 37863815
[TBL] [Abstract][Full Text] [Related]
2. Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.
Li X; Dong M; Lin Q; Chen ZH; Ma XK; Xing YF; Wan XB; Wen JY; Wei L; Chen J; Wu XY
Asia Pac J Clin Oncol; 2013 Mar; 9(1):86-92. PubMed ID: 23279888
[TBL] [Abstract][Full Text] [Related]
3. Clinical prediction for outcomes of patients with acute-on-chronic liver failure associated with HBV infection: A new model establishment.
Fan W; Liao W; Luo Y; You B; Yu J; Li C
Open Med (Wars); 2020; 15(1):714-722. PubMed ID: 33336028
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of the CLIP scoring system for prediction of postoperative prognosis of patients with large hepatocellular carcinoma.
Noda T; Sasaki Y; Yamada T; Eguchi H; Yano M; Ohigashi H; Ishikawa O; Imaoka S
J Hepatobiliary Pancreat Surg; 2009; 16(4):538-45. PubMed ID: 19367360
[TBL] [Abstract][Full Text] [Related]
5. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
Kudo M; Chung H; Osaki Y
J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
[TBL] [Abstract][Full Text] [Related]
6. Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma.
Omagari K; Honda S; Kadokawa Y; Isomoto H; Takeshima F; Hayashida K; Mizuta Y; Murata I; Kohno S
J Gastroenterol Hepatol; 2004 Jul; 19(7):805-11. PubMed ID: 15209629
[TBL] [Abstract][Full Text] [Related]
7. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial Therapy.
Sohn JH; Duran R; Zhao Y; Fleckenstein F; Chapiro J; Sahu S; Schernthaner RE; Qian T; Lee H; Zhao L; Hamilton J; Frangakis C; Lin M; Salem R; Geschwind JF
Clin Gastroenterol Hepatol; 2017 May; 15(5):746-755.e4. PubMed ID: 27847278
[TBL] [Abstract][Full Text] [Related]
9. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
10. The size of the problem: clinical algorithms.
Forner A; Bruix J
Dig Dis; 2013; 31(1):95-103. PubMed ID: 23797130
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the Predictive Values of Eight Staging Systems for Primary Liver Cancer in Prognosis of Combined Hepatocellular-cholangiocellular Carcinoma Patients after Surgery].
Li H; Wang XT; Zhang AQ; Meng XF; Yu Q; Lü WP; Duan WD; Dong JH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Apr; 38(2):175-81. PubMed ID: 27181894
[TBL] [Abstract][Full Text] [Related]
12. Updated treatment approach to hepatocellular carcinoma.
Llovet JM
J Gastroenterol; 2005 Mar; 40(3):225-35. PubMed ID: 15830281
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of four scoring systems in liver transplant recipients.
Bein T; Fröhlich D; Pömsl J; Forst H; Pratschke E
Intensive Care Med; 1995 Jan; 21(1):32-7. PubMed ID: 7560471
[TBL] [Abstract][Full Text] [Related]
14. Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization.
Georgiades CS; Liapi E; Frangakis C; Park JU; Kim HW; Hong K; Geschwind JF
J Vasc Interv Radiol; 2006 Oct; 17(10):1619-24. PubMed ID: 17057003
[TBL] [Abstract][Full Text] [Related]
15. Advanced hepatocellular carcinoma: which staging systems best predict prognosis?
Huitzil-Melendez FD; Capanu M; O'Reilly EM; Duffy A; Gansukh B; Saltz LL; Abou-Alfa GK
J Clin Oncol; 2010 Jun; 28(17):2889-95. PubMed ID: 20458042
[TBL] [Abstract][Full Text] [Related]
16. Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort.
Adhoute X; Pénaranda G; Raoul JL; Edeline J; Blanc JF; Pol B; Campanile M; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Castellani P; Le Treut YP; Bronowicki JP; Bourlière M
World J Gastroenterol; 2017 Apr; 23(14):2545-2555. PubMed ID: 28465639
[TBL] [Abstract][Full Text] [Related]
17. Pediatric liver tumors.
Reynolds M
Semin Surg Oncol; 1999 Mar; 16(2):159-72. PubMed ID: 9988870
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hepatocellular carcinoma.
Liccioni A; Reig M; Bruix J
Dig Dis; 2014; 32(5):554-63. PubMed ID: 25034288
[TBL] [Abstract][Full Text] [Related]
19. Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients.
Heinrich S; Sprinzl M; Schmidtmann I; Heil E; Koch S; Czauderna C; Heinrich B; Philippe P Diggs L; Wörns MA; Kloeckner R; Galle PR; Marquardt JU; Weinmann A
United European Gastroenterol J; 2020 May; 8(4):444-452. PubMed ID: 32213028
[TBL] [Abstract][Full Text] [Related]
20. [The treatment of hepatocellular carcinoma: an update].
Vero V; Racco S; Biolato M; Pompili M; Gasbarrini G; Miele L; Grieco A
Minerva Med; 2009 Jun; 100(3):173-93. PubMed ID: 19571783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]